Chemical Compound
15-epi-Prostaglandin E1; Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11a,13E,15R)-; Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, stereoisomer (8CI); (11a,13E,15R)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid; 15(R)-PGE1; 15-Epi-PGE1; 15-Epiprostagland
CAS Registry Number
20897-91-0
Primary record
15-epi-Prostaglandin E1; Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11a,13E,15R)-; Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, stereoisomer (8CI); (11a,13E,15R)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid; 15(R)-PGE1; 15-Epi-PGE1; 15-Epiprostagland
- 库存
- 4,453 克
- 纯度
- 99.6 %
- CAS
- 20897-91-0
化合物标识与属性
- CAS
- 20897-91-0
- PubChem CID
- 5283056
- SMILES
- CCCCC[C@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O
- Canonical SMILES
- CCCCC[C@@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O
名称与同义词
- 15(R)-Prostaglandin E1
- 15-Epiprostaglandin E1
- alprostadil
- 15-epi-PGE1
- 20897-91-0
- 15R-Prostaglandin E1
- 15(R)-PGE1
- V2N896SN9V
- AC1NR1FD
- PGE1
- UNII-V2N896SN9V
- Prostaglandin Impurity N2
- 15-epi-Prostaglandin E1
- Alprostadil impurity D [EP]
- RefChem:1057533
- Alprostadil EP Impurity D
- CHEMBL62570
- 15R-PGE1
- 15-EPI PGE1
- DTXSID701347929
- orb2567281
- 15(R)-PROSTAGLANDINE1
- C20H34O5
- SCHEMBL11786980
- CHEBI:182985
- GMVPRGQOIOIIMI-CHCORRSHSA-N
- DTXCID501776667
- HMS3648D07
- ZINC3830202
- 1213AH
- BDBM50101828
- LMFA03010055
- MFCD00036683
- CID5283056
- Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15R)-
- BP183529
- PD021165
- 9-oxo-11R,15R-dihydroxy-13E-prostaenoic acid
- HY-116096
- J428.380E
- 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3R)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid
- ALPROSTADIL IMPURITY D [EP IMPURITY]
- CS-0063768
- AE-641/01143043
- SR-01000946408
- 15(R)-Prostaglandin E1; Alprostadil EP Impurity D
- SR-01000946408-1
- Q27291453
- 7-((1R,2R,3R)-3-Hydroxy-2-((1E,3R)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid
- (11alpha,13E,15R)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
- (13E,15R)-11alpha,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
- 7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3R)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid
- 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3R)-3-hydroxyoct-1-enyl]-5-oxo-cyclopentyl]heptanoic acid
- 15(R)-PGE1; 15-epi PGE1; 9-oxo-11|A,15R-dihydroxy-prost-13E-en-1-oic acid; 7-((1R,2R,3R)-3-hydroxy-2-((R,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid
- 15-epi-Prostaglandin E1; Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11a,13E,15R)-; Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, stereoisomer (8CI); (11a,13E,15R)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid; 15(R)-PGE1; 15-Epi-PGE1; 15-Epiprostagland
- 7-[(1R,2R,3R)-3-Hydroxy-2-((E)-(R)-3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid
- 7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoic acid